Beyond Air (XAIR) Return on Capital Employed (2017 - 2026)
Beyond Air (XAIR) reported Return on Capital Employed of 98.23% for Q1 2026, up 6611.0% on a YoY basis from 1.46% in Q1 2025, and up 2.34% sequentially from 100.58% in Q4 2025.
Beyond Air (XAIR) Return on Capital Employed (2017 - 2026) Analysis & Trends
Beyond Air (XAIR) has 10 years of Return on Capital Employed data on file, last reported at 98.23% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 6611.0% year-over-year to 98.23%; the trailing twelve-month figure through Mar 2026 stood at 98.23% (up 6611.0% YoY), and the FY2026 full-year result was 110.8%, up 484.0% from the prior year.
- Return on Capital Employed advanced to 98.23% in Q1 2026, from 100.58% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 45.98% in Q1 2022 to a low of 164.33% in Q1 2025.
- A 5-year average of 113.58% and a median of 115.71% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 6048 bps in 2023 and soared 6611 bps in 2026, its largest moves.
- Tracing XAIR's Return on Capital Employed over 5 years: stood at 88.1% in 2022, then plunged by 69 bps to 148.58% in 2023, then increased by 12 bps to 131.07% in 2024, then advanced by 23 bps to 100.58% in 2025, then rose by 2 bps to 98.23% in 2026.
- Business Quant data shows XAIR's Return on Capital Employed at 98.23% in Q1 2026, 100.58% in Q4 2025, and 132.78% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Beyond Air | 2.25 Mn | -10.02 Mn | 94,000.00 | -98.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -98.23% |
| Dec 31, 2025 | -100.58% |
| Sep 30, 2025 | -132.78% |
| Jun 30, 2025 | -157.70% |
| Mar 31, 2025 | -164.33% |
| Dec 31, 2024 | -131.07% |
| Sep 30, 2024 | -129.78% |
| Jun 30, 2024 | -151.87% |
| Mar 31, 2024 | -146.98% |
| Dec 31, 2023 | -148.58% |
| Sep 30, 2023 | -115.71% |
| Jun 30, 2023 | -95.95% |
| Mar 31, 2023 | -100.94% |
| Dec 31, 2022 | -88.10% |
| Sep 30, 2022 | -68.96% |
| Jun 30, 2022 | -53.35% |
| Mar 31, 2022 | -45.98% |
| Dec 31, 2021 | -35.90% |
| Sep 30, 2021 | -55.55% |
| Jun 30, 2021 | -58.67% |